Sign In
Buy LLY
$1,192.80
+22.94 (+1.96%)
At Close: Aug 06, 2026
Jim Cramer names his top 5 stock picks, dismisses dot-com style meltdown
02:51pm, Saturday, 16'th Aug 2025
Former hedge fund manager and CNBC's Mad Money host Jim Cramer has dismissed fears that the stock market might be heading for another Dot-com style meltdown.
Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet.
08:45am, Saturday, 16'th Aug 2025
Wall Street loves a dominant player, and Eli Lilly (LLY 2.73%) looks unstoppable with its obesity blockbusters printing money faster than the Fed. But here's what the bulls aren't telling you: The com
What Moved Markets This Week
07:18am, Saturday, 16'th Aug 2025
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst
01:54pm, Friday, 15'th Aug 2025
On Thursday, Eli Lilly and Co. LLY said it will sharply increase the list price of its weight-loss and type 2 diabetes drug Mounjaro (tirzepatide) in the United Kingdom.
Novo Nordisk Stock Could Benefit From Eli Lilly's Weight-Loss Price Hikes
12:25pm, Friday, 15'th Aug 2025
The pricing of weight-loss drugs like Lilly's Zepbound and Novo's Wegovy is a pressure point for investors.
Eli Lilly signs $1.3 billion deal with Superluminal to use AI to make obesity medicines
07:53am, Friday, 15'th Aug 2025
Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases.
Eli Lilly to hike UK price of weight-loss drug Mounjaro
03:48am, Friday, 15'th Aug 2025
Eli Lilly and Co (NYSE:LLY) will raise the UK list price of its weight-loss injection Mounjaro by up to 170% from September, increasing the cost of a month's supply of the highest dose from £122 to �
Eli Lilly raises price of diabetes drug Mounjaro in UK ahead of Trump deadline
06:26pm, Thursday, 14'th Aug 2025
Dr. Kavita Patel, NBC News & MSNBC medical contributor, joins 'Fast Money' to talk Eli Lilly raising Mounjaro prices.
Guidance Watch: 2 Companies Bullishly Raising Forecasts
06:21pm, Thursday, 14'th Aug 2025
One company remains at the forefront of the AI frenzy, whereas the other has seen insiders dive in post-earnings.
The move is part of the company's plan to renegotiate drug prices across other developed nations
Top Stock Movers Now: Tapestry, Deere, Eli Lilly, and More
12:20pm, Thursday, 14'th Aug 2025
U.S. equities were lower at midday as wholesale inflation rose more than expected in July. The Dow Jones Industrial Average, S&P 500, and Nasdaq were all down.
Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs
12:00pm, Thursday, 14'th Aug 2025
Eli Lilly said it is raising the list price of its blockbuster diabetes drug Mounjaro in the U.K. starting in September. It comes as President Donald Trump pressures drugmakers to lower U.S. drug pric
Lanier Law Firm Representing Health Choice Alliance in Litigation Alleging Eli Lilly Offered Kickbacks to Texas Health Care Providers
11:23am, Thursday, 14'th Aug 2025
MARSHALL, Texas--(BUSINESS WIRE)--Texas Attorney General Ken Paxton has filed a lawsuit in state court against Eli Lilly and Co., accusing the pharmaceutical giant of bribing and inducing medical prov
Eli Lilly to hike UK price of Mounjaro weight-loss, diabetes medicines by 170%
08:55am, Thursday, 14'th Aug 2025
Eli Lilly will raise the list price in the UK of its weight-loss and type 2 diabetes treatment Mounjaro by 170% to be in line with other European markets, the U.S. drugmaker said on Thursday.
Lilly signs up to $1.3 billion deal with Superluminal Medicines to develop obesity medicines
08:16am, Thursday, 14'th Aug 2025
Eli Lilly has signed a deal worth up to $1.3 billion with privately held Superluminal Medicines to discover and develop drugs targeting cardiometabolic diseases and obesity, Superluminal said on Thurs
